Indica Labs

Directions Website

Indica Labs Indica Labs is the world’s leading provider of computational pathology software and image analysis services.

Indica Labs is proudly located in Albuquerque, New Mexico. Our software development and IT support team are experts in their respective fields including image analysis, artificial intelligence, web development, databases, network architecture, and security. To support our customers, our PhD-level application scientists and pharma services team members are ready to assist you to advance tissue-based research.

is here, and we're excited to start our time in San Diego with our workshop alongside Versant Diagnostics and Leica Bi...
10/16/2026

is here, and we're excited to start our time in San Diego with our workshop alongside Versant Diagnostics and Leica Biosystems!

Join us at noon in Seaport G for “Beyond Go-Live: Building a Computational Pathology Network That Actually Works” to hear perspectives from a practicing pathologist and operational stakeholders, with a focus on lessons learned from real-world computational pathology adoption across a multi-site practice.

See you soon!

View the session details: https://digitalpathologyassociation.org/pv26-agenda/show/session/217

10/15/2026

A stronger foundation for digital pathology. A shared vision for precision medicine.

and are expanding their strategic partnership to support high-volume clinical operations through a scalable, cloud-based deployment of HALO AP.

The expanded collaboration will modernize NeoGenomics’ enterprise digital pathology infrastructure, support broader AI adoption across clinical operations and biomarker analysis, and establish a framework for future companion diagnostic (CDx) initiatives.

With NeoGenomics serving approximately 4,400 medical sites and performing more than 1.7 million cancer-related tests annually, this partnership brings together substantial oncology expertise and Indica Labs’ AI-powered digital pathology capabilities.

Read the announcement: https://bit.ly/4hVJZIj

👀 Don't miss the chance to see what AI model interoperability looks like in practice.Join us on 4 November for our upcom...
10/14/2026

👀 Don't miss the chance to see what AI model interoperability looks like in practice.

Join us on 4 November for our upcoming masterclass webinar, where Donald Allen, Product Manager for HALO AI, will demonstrate three distinct approaches for connecting AI models with digital pathology workflows.

During the session, Donald will demonstrate how users can:
✅ Bring an externally developed ONNX model into HALO for image analysis
✅ Export a model trained in HALO AI to ONNX and run inference in an external Python workflow
✅ Connect a containerized custom model to HALO through the HALO API while keeping the model in its native software environment

Catch the webinar to see these workflows in action and learn how you can take advantage of the freedom and flexibility offered by HALO to combine internally developed, third-party, and HALO AI models with the workflows that fit your science.

Learn more and register today: https://indicalab.com/events/open-ai-workflows-in-digital-pathology-model-interoperability-with-halo/

We’re excited that our own Dr. Natasha Carmell and Dr. Robyn Broad are at ELRIG's Drug Discovery 2026 and sharing how th...
10/14/2026

We’re excited that our own Dr. Natasha Carmell and Dr. Robyn Broad are at ELRIG's Drug Discovery 2026 and sharing how the HALO ADC Target Scoring module, along with HALO AI, is designed to unlock new insights into target biology!

Drop by their poster to learn about the module’s capabilities for measuring target expression across membrane and cytoplasmic compartments, including normalized membrane ratio, membrane staining variability and completeness, and quantitative continuous scoring. The poster also details the module's spatial tools for examining the relationship between target-positive and neighboring target-negative cells, providing additional context for investigating potential bystander effects.

If ADC are part of your discovery pipeline, stop by during the poster sessions to meet Natasha and Robyn and get a closer look at the streamlined workflows and in-depth measurements provided by HALO and HALO AI.

Don't miss it: this morning at Biomarkers, CDx & Precision Medicine Europe, our Director of AI Research, Dr. John-Melle ...
10/13/2026

Don't miss it: this morning at Biomarkers, CDx & Precision Medicine Europe, our Director of AI Research, Dr. John-Melle Bokhorst, will present “Your Model Is Not a Solution: From Biomarker Discovery to Clinical Deployment.”

John-Melle will explore what it takes to move beyond model performance and build AI-enabled workflows that can be validated, integrated, and ultimately trusted in real-world clinical settings.

If you’re attending in Basel, we hope you’ll join the discussion!

10/12/2026

If you're looking for deeper insights from tissue image analysis to help reach your biomarker or companion diagnostic project goals, be sure to visit our team at Biomarkers, CDx & Precision Medicine Europe 2026, starting tomorrow!

Drop by booth #70 to explore how our platforms help teams turn complex pathology images into quantitative data that informs biomarker and CDx development. With HALO, HALO AI, and HALO Link, organizations can build workflows that span tissue and cell characterization, custom AI development, spatial and high-dimensional analysis, and collaborative management of images, data, and results across studies.

If you're in Basel, stop by our booth to meet the team, see HALO in action, and talk through the challenges you're tackling in your own program.

We look forward to seeing you, and if you'd like to schedule a meeting with our team, you can select a time here: https://calendly.com/indicalabs/indica-labs-biomarkers-eu

In case you missed it: Our webinar exploring work at the National Cancer Institute to automate tissue macrodissection is...
10/08/2026

In case you missed it: Our webinar exploring work at the National Cancer Institute to automate tissue macrodissection is now online! Scott Lawrence, Algorithm Engineer IV and Associate Scientist at Leidos Biomedical Research, detailed the team's integrated ecosystem--including HALO platforms and the Xyall Tissector automated tissue dissector--their validation, quality, and yield data, and next steps.

If you're considering automating some of your lab's macrodissection workload, check out the recording for an in-depth discussion of the reality of automated approaches!

Watch here: https://indicalab.com/events/automating-tissue-macro-dissection-with-insight/

Did you hear the news? We’ve partnered with Voicebrook, Inc. to integrate their industry-leading VoiceOver PRO reporting...
10/06/2026

Did you hear the news? We’ve partnered with Voicebrook, Inc. to integrate their industry-leading VoiceOver PRO reporting workflow platform with our AI-driven HALO AP digital pathology platform! Thanks to seamless integration with our HALO Clinical AI solutions, biomarker results automatically flow into the appropriate CAP cancer protocol checklist, giving pathologists working biomarker-driven cases a single reporting workflow:

✅ Slides are navigated by voice in HALO AP
✅ The right CAP checklist is automatically selected
✅ The quantitative biomarker results from HALO Clinical AI are already in place
✅ The pathologist's attention stays on interpretation rather than data entry

“Integrating Voicebrook's speech-driven navigation directly into HALO AP gives pathologists a more natural, hands-free way to interact with their digital pathology workflow,” notes Hallie Rane, our Product Manager of Clinical Applications. “Whether they are navigating cases, documenting findings, or interacting with AI-driven image analysis, pathologists can use their voice to perform key tasks without stepping away from the slide.”

Read our joint press release to learn more: https://indicalab.com/news/press-release/voicebrook-announces-digital-pathology-integration-with-indica-labs-delivering-automated-ai-biomarker-reporting-and-hands-free-navigation/

A high-performing AI model is only one part of the journey from biomarker discovery to patient impact.Join Dr. John-Mell...
10/05/2026

A high-performing AI model is only one part of the journey from biomarker discovery to patient impact.

Join Dr. John-Melle Bokhorst, our Director of AI Research, at Biomarkers, CDx & Precision Medicine Europe for a presentation that looks beyond model development to the broader capabilities required to turn computational pathology insights into deployable solutions. Spanning validation, clinical development, regulatory considerations, and integration into real-world workflows, John-Melle will discuss what it takes to bridge the gap between promising AI research and meaningful clinical use.

We look forward to seeing you there!

10/02/2026

In case you missed it: version 4.4 of HALO, HALO AI, and HALO Link is out now, and there's no better highlight of the new features in this release than our recent sneak peek webinar!

If you couldn't make it to the live event, follow the link below to watch the recording and learn about all the powerful new features, including customizable fluorescent channel grouping options that streamline interaction with multiplex images, the Object Data Gallery for easy object QC, new AI architectures, and much more.

Watch now: https://indicalab.com/events/learn-about-the-exciting-new-features-in-the-4-4-versions-of-halo-halo-ai-and-halo-link/

Address

8700 Education Place NW, Bldg. B
Albuquerque, NM
87114

Website

Alerts

Be the first to know and let us send you an email when Indica Labs posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category